Multidrug and Extensive Drug Resistance in Pseudomonas aeruginosa Clinical Isolates from a Portuguese Central Hospital: 10-Year Survey

Microbial Drug Resistance

Volumn 21, Issue 2, 2015, Pages 194-200

  Pereira, Sónia Gonçalves ^a   Marques, Margarida ^b   Pereira, João ^b   Cardoso, Olga ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; FEMALE; HOSPITAL; HUMAN; MALE; NONHUMAN; PORTUGAL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; ADOLESCENT; CROSS INFECTION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PHYSIOLOGY; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENTAMICINS; HOSPITALS; HUMANS; IMIPENEM; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84925940700     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0137     Document Type: Review

References (22)

1. Battle, S. E. , J. Rello, and A. R. Hauser. 2009. Genomic islands in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 290:70-78.
2. Benjamini, Y. , and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57:289-300.
3. Breathnach, A. S. , M. D. Cubbon, R. N. Karunaharan, C. F. Pope, and T. D. Planche. 2012. Multi-drug resistant Pseudomonas aeruginosa outbreaks in two hospitals: association with contaminated hospital waste-water systems. J. Hosp. Infect. 82:19-24.
4. Cabot, G. , A. A. Ocampo-Sosa, M. A. Dominguez, C. Juan, F. Tubau, C. Rodriguez, B. Moya, C. Penã, L. Martinez-Martinez, A. Oliver, and Spanish Network for Research in Infectious Diseases (REIPI). 2012. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob. Agents Chemother. 56:6349-6357.
5. Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA
6. European Centre for Disease Prevention and Control. 2008. European Antimicrobial Resistance Surveillance System Annual Report 2007. Bilthoven, ECDC.
7. European Centre for Disease Prevention and Control. 2009. European Antimicrobial Resistance Surveillance System Annual Report 2008: on-going surveillance of S. pneumonia, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. Bilthoven, ECDC.
8. European Centre for Disease Prevention and Control. 2010. Antimicrobial resistance surveillance in Europe 2009: annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC.
9. European Centre for Disease Prevention and Control. 2011. Antimicrobial resistance surveillance in Europe 2010: annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC.
10. European Centre for Disease Prevention and Control. 2012. Antimicrobial resistance surveillance in Europe 2011: annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC.
11. European Centre for Disease Prevention and Control. 2013. Antimicrobial resistance surveillance in Europe 2012: annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC.
12. Falagas, M. E. , and I. A. Bliziotis. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29:630-636.
13. Folkensson, A. , L. Jelsbak, L. Yang, H. K. Johansen, O. Ciofu, N. H\Oiby, and S. Molin. 2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10:841-851.
14. Fricks-Lima, J. , C. M. Hendrickson, A. Allgaier, H. Zhuo, J. P. Wiener-Kronish, S. V. Lynch, and K. Yang. 2011. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Int. J. Antimicrob. Agents 37:309-315.
15. Hirsch, E. B. , and V. H. Tam. 2010. Impact of multidrugresistant Pseudomonas aeruginosa infection in patients outcomes. Expert Rev. Pharmacoecon. Outcomes Res. 10: 441-451.
16. Kanj, S. S. , and D. J. Sexton. 2012. Epidemiology and pathogenesis of Pseudomonas aeruginosa infections. Available at www. uptodate. com/contents/epidemiology-andpathogenesis-of-pseudomonas-aeruginosa-infection. Upto-Date-, accessed 9th June 2014 (Online. ).
17. Lister, P. D. , D. J. Wolter, and N. D. Hanson. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
18. Magiorakos, A.-P. , A. Srinivasan, R. B. Carey, Y. Carmeli, M. E. Falagas, C. G. Giske, S. Harbarth, J. F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, D. L. Paterson, L. B. Rice, J. Stelling, M. J. Struelen, A. Vatopoulos, J. T. Weber, and D. L. Monnet. 2011. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:268-281.
19. Mesaros, N. , P. Nordmann, P. Plesiat, M. Roussel-Delvallez, J. Van Eldere, Y. Glupczynski, Y. Van Laethem, F. Jacobs, P. Lebecque, A. Malfroot, P. M. Tulkens, and F. Van Bambeke. 2007. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect. 13:560-578.
20. Penã, C. , S. Gomez-Zorrilla, C. Suarez, M. A. Dominguez, F. Tubau, O. Arch, A. Oliver, M. Pujol, and J. Ariza. 2012. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 31:2791-2797.
21. Strateva, I. , and D. Yordanov. 2009. Pseudomonas aeruginosa-A phenomenon of bacterial resistance. J. Med. Microbiol. 58:1133-1148.
22. Walsh, T. 2010. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents 36S3:S8-S14.